Prosight Management

Prosight Management as of Dec. 31, 2021

Portfolio Holdings for Prosight Management

Prosight Management holds 36 positions in its portfolio as reported in the December 2021 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Prothena Corp SHS (PRTA) 13.0 $22M 441k 49.40
Galapagos Nv Spon Adr (GLPG) 11.4 $19M 346k 55.13
Albireo Pharma 7.2 $12M 514k 23.29
Galapagos Nv Call Call Option 6.6 $11M 200k 55.13
Cue Biopharma (CUE) 5.6 $9.4M 829k 11.31
Encompass Health Corp (EHC) 4.8 $8.0M 122k 65.26
Oscar Health Cl A (OSCR) 4.3 $7.3M 925k 7.85
Convey Hldg Parent 3.9 $6.5M 777k 8.36
Kezar Life Sciences (KZR) 3.6 $6.0M 360k 16.72
Zogenix Com New 3.5 $5.9M 363k 16.25
Charles River Laboratories (CRL) 3.5 $5.8M 16k 376.78
Kalvista Pharmaceuticals (KALV) 3.2 $5.4M 410k 13.23
Alnylam Pharmaceuticals (ALNY) 3.2 $5.4M 32k 169.59
Aldeyra Therapeutics (ALDX) 2.8 $4.6M 1.2M 4.00
Arena Pharmaceuticals Com New 2.5 $4.2M 45k 92.93
Agilon Health (AGL) 2.4 $4.1M 150k 27.00
Morphic Hldg (MORF) 2.1 $3.5M 73k 47.38
Proqr Thrapeutics N V Shs Euro (PRQR) 1.7 $2.9M 357k 8.01
Rocket Pharmaceuticals (RCKT) 1.7 $2.8M 129k 21.83
Prothena Corp Call Call Option 1.5 $2.6M 52k 49.41
Progyny Put Put Option 1.5 $2.5M 50k 50.36
Shattuck Labs (STTK) 1.3 $2.2M 260k 8.51
Cognition Therapeutics (CGTX) 1.1 $1.9M 302k 6.32
Panacea Acquisition Corp Ii Cl A Shs 1.1 $1.9M 196k 9.70
Globus Med Cl A (GMED) 0.9 $1.5M 20k 72.22
Accolade (ACCD) 0.8 $1.3M 50k 26.36
Crispr Therapeutics Namen Akt (CRSP) 0.8 $1.3M 17k 75.79
Iovance Biotherapeutics (IOVA) 0.8 $1.3M 69k 19.08
Sio Gene Therapies Common 0.6 $1.0M 802k 1.29
Moderna (MRNA) 0.6 $940k 3.7k 254.05
West Pharmaceutical Svsc Put Put Option 0.4 $704k 1.5k 469.33
Cymabay Therapeutics 0.3 $564k 167k 3.38
Procept Biorobotics Corp (PRCT) 0.3 $500k 20k 25.00
Exicure 0.3 $490k 2.4M 0.20
Odonate Therapeutics Ord 0.2 $404k 299k 1.35
Silverback Therapeutics (SPRY) 0.2 $358k 54k 6.65